Insiders · Profile

Hochman David P

See Remarks at Orchestra BioMed · Director at Corbus Pharmaceuticals. Filing since 25 Nov 2014. CIK 0001292834

Company
Date
Role
Action
Shares
Amount
Of holding
3 Sep 2026
See Remarks
Bought
10,000
$47.90K
0.9%
1 Jun 2026
See Remarks
Bought
5,000
$19.15K
0.5%
15 May 2026
See Remarks
Bought
5,000
$18.85K
0.5%
13 Mar 2026
See Remarks
Bought
10,000
$42.90K
0.9%
14 Nov 2025
See Remarks
Bought
5,000
$20.35K
0.8%
21 Aug 2025
See Remarks
Bought
6,000
$14.94K
0.9%
4 Aug 2025
See Remarks
Bought
20,000
$55.00K
6.1%
23 Dec 2024
See Remarks
Bought
4,000
$18.64K
0.7%
18 Dec 2024
See Remarks
Bought
5,000
$24.55K
0.9%
25 Sep 2024
See Remarks
Bought
7,500
$35.63K
2.3%
24 Sep 2024
See Remarks
Bought
2,500
$12.28K
0.4%
14 Aug 2024
See Remarks
Bought
2,500
$14.60K
0.4%
25 Jun 2024
See Remarks
Bought
1,000
$6.95K
0.3%
15 Mar 2019
Director
Bought
2,000
$13.96K
40.0%
14 May 2018
Director
Bought
5,000
$27.38K
opened
14 Mar 2018
Director
Bought
5,000
$33.33K
2.3%
15 Nov 2017
Director
Bought
5,000
$32.75K
2.3%
10 Nov 2017
Director
Bought
10,000
$70.80K
2.2%
11 May 2017
Director
Bought
3,400
$21.01K
0.7%
18 Nov 2016
Director
Bought
10,000
$69.96K
2.2%
22 Aug 2016
Director
Bought
1,800
$6.79K
0.4%
17 Aug 2015
Director
Bought
1,000
$1.92K
0.2%
4 Dec 2014
Director
Bought
1,300
$3.97K
0.3%
2 Dec 2014
Director
Bought
900
$3.05K
0.2%
1 Dec 2014
Director
Bought
500
$2.00K
0.1%
25 Nov 2014
Director
Bought
2,000
$6.17K
0.5%
26 decisions on file.